image

The best stocks to buy since 1993

Latest issue now available

Supreme - Trading ahead of expectations

May 2026

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SUP
  • Price:
  • 162.5p
CEO Sandy Chadha has again knocked the ball clean out of the park with profits for the year to 31 March expected to be “significantly ahead of market expectations.” Sales are forecast at +15% to £265m, with EBITDA hitting £40.6m, slightly ahead of last year’s £40.5m and compared with forecasts of £36.4m. Supreme even managed to end the year with net cash of c£3m. Particularly impressive is the Vaping side, which delivered sales more than 10% higher than last year - despite the UK disposable vape ban kicking in on 1 June 2025, threatening to kneecap the division. The Drinks & Wellness category also put in a strong shift, helped by the first time contribution from SlimFast. Keep on buy list. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe